domingo, 15 de agosto de 2021

Heterologous ChAdOx1-nCoV19–BNT162b2 vaccination provides superior immunogenicity against COVID-19 - The Lancet Respiratory Medicine

Heterologous ChAdOx1-nCoV19–BNT162b2 vaccination provides superior immunogenicity against COVID-19 - The Lancet Respiratory Medicine

No hay comentarios:

Publicar un comentario